Clinical Outcomes of Various Management Strategies for Symptomatic Bradycardia
- PMID: 32060043
- PMCID: PMC7428208
- DOI: 10.3121/cmr.2019.1507
Clinical Outcomes of Various Management Strategies for Symptomatic Bradycardia
Abstract
Objective: To determine clinical outcomes of various management strategies for reversible and irreversible causes of symptomatic bradycardia in the inpatient setting.
Design: Retrospective observational study.
Setting: Emergency room and inpatient.
Participants: Patients presenting to the emergency department with symptomatic bradycardia.
Methods: We retrospectively reviewed electronic health records of 518 patients from two Mayo Clinic campuses (Rochester and Phoenix) who presented to the emergency department with symptomatic bradycardia (heart rate ≤50 beats/minute) from January 1, 2010 through December 31, 2015. Sinus bradycardia was excluded. The following management strategies were compared: observation, non-invasive management (medications with/without transcutaneous pacing), early permanent pacemaker (PPM) implantation (≤2 days), and delayed PPM implantation (≥3 days). Study endpoints included length of stay and adverse events related to bradycardia (syncope, central line-associated bloodstream infections, cardiac arrest, and in-hospital mortality). Patients who received a PPM were further stratified by weekend hospital admission.
Results: Heart block occurred in 200 (38.6%) patients, and atrial arrhythmias with slow ventricular response occurred in 239 (46.1%) patients. Reversible causes of bradycardia included medication toxicity in 22 (4.2%) patients and hyperkalemia in 44 (8.5%) patients. Adverse events were similar in patients who underwent early compared to delayed PPM implantation (6.6% vs 12.5%, P=.20), whereas adverse events were higher in patients who received temporary transvenous pacing (19.1% vs 3.4%, P<.001). Weekend admissions were associated with increased temporary transvenous pacing, prolonged median time to PPM implantation by 1 day, and prolonged median length of stay by 2 days.
Conclusions: Delayed PPM implantation was not associated with an increase in adverse events. Weekend PPM implantation should be considered to reduce temporary transvenous pacing and shorten length of stay.
Keywords: Artificial; Bradycardia; Heart Block; Pacemaker.
© 2020 Marshfield Clinic.
Figures
References
-
- Samii SM. Indications for pacemakers, implantable cardioverter-defibrillator and cardiac resynchronization devices. Med Clin North Am. 2015;99(4):795–804. - PubMed
-
- Kusumoto FM, Schoenfeld MH, Barrett C, et al. . 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2019;74(7):e51–e156. - PubMed
-
- Greenspon AJ, Patel JD, Lau E, et al. . Trends in permanent pacemaker implantation in the United States from 1993 to 2009: increasing complexity of patients and procedures. J Am Coll Cardiol. 2012;60(16):1540–1545. - PubMed
-
- Risgaard B, Elming H, Jensen GV, Johansen JB, Toft JC. Waiting for a pacemaker: is it dangerous? Europace. 2012;14(7):975–980. - PubMed
-
- Simpson CS, Fisher MA, Curtis MJ, et al. . Correlation of waiting time with adverse events in patients admitted for nonelective permanent pacemaker implantation. Can J Cardiol. 1998;14(6):817–821. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical